Arcinova offers a full suite of drug substance, drug product and analytical support services from preclinical through to small scale commercial. We have a big company track record and compliance (ex-Sanofi, Covance) coupled with the responsiveness and agility of a smaller company. We also partner with Covance to deliver fully integrated solutions.
Our legacy customer base has now grown to over 116 since we bought our site in Alnwick, Northumberland, UK from Covance in February 2016 and rebranded as Arcinova. We are very keen to meet new partners and help them progress their candidates into the clinic and through trials.
Dr Nathalie HutherBusiness Development Manager Europe
Dr Mark ChadwickHead of Business Development
Biopartner UK leads the UK Delegation to several partnering conferences each year. It is a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with Life Sciences organisations across the UK. BioPartner is a membership organisation, supporting UK SMEs and startups, and signposting organisations worldwide to UK expertise.
Biopartner has alliances with organisers of international biopartnering events, and with UK membership organisations, operating both independently and in partnership with the UK government. BioPartner disseminates tradeshow access grants to help UK-based SMEs exhibit their services and products in new overseas markets.
Della Bateson-ChaffeFinance Officer
Sarah ArcherMissions & Events Coordinator
Clinical Network Services (UK)
Clinical Network Services (CNS) is an integrated service group focused on product development headquartered in Australia with offices in New Zealand, the UK and the USA.
CNS creates value for small-medium sized biotechnology companies by progressing early stage products through phase 1 & 2 clinical trials or the marketplace sooner.
With over 20 years’ experience on more than 650 projects, CNS is one of the most experienced providers within the market and a partner of choice for biotech companies.
Mr Paul CroninDirector
Mr Russell NealManaging Director
Colibri Scientific provides fast and flexible clinical sample operational services to clinical investigators, biotechnology and pharmaceutical companies running small to medium scale multi-centre studies. Our team is made up of industry experts with many years’ experience in the field.
As our name suggests (Colibri – hummingbird), we are a small, agile and efficient company which offers a fully customisable service to meet the needs of our clients; something that is difficult to achieve from larger organisations. We aim to deliver the specific sample requirements of your trial, regardless how small, using a flexible approach together with scientific rigour and organisational expertise.
Mrs Sue KeelerManaging Director
CPRD (Clinical Practice Research Datalink) is the leading provider of integrated real-world research services based on longitudinal representative UK population EHR data. We provide anonymised data to academic, industry and government institutions worldwide to support public health observational research in addition to supporting recruitment of patients to clinical studies, bespoke data collection and full pragmatic trial management.
CPRD is a UK government initiative sponsored by the Medicines and Healthcare products Regulatory Agency and the National Institute for Health Research, to drive real world evidence in public health research.
CPRD provides an integrated service from discovery to post-marketing evaluation which can maximise study endpoints, data quality and generalisability. We offer real-world clinical services based on electronic health records from a UK network of research-active general practices.
- Longitudinal representative data for research – Research-ready anonymised data collated from more than 20 million patients’ electronic health records. With over 30 years’ experience, CPRD’s in-house research team of epidemiologists and statisticians offers advice and support to advance customers’ public health research
- Bespoke data collection – CPRD can assist with the collection of study-specific data to supplement electronic health record data including electronic patient reported outcomes and physician questionnaires
- Recruitment services – CPRD can conduct patient eligibility searches and manage the informed consent process for clinical studies in primary and secondary care settings.
- Trial management services - CPRD offers full management of post-marketing real-world clinical effectiveness studies and pragmatic trials in primary care.
Dr David Mark WrightHead of Clinical Trials
Dr Róisín NicAmhlaoibhHead of Business Development
Oncology specialised contract clinical research company providing flexible, customised, bespoke clinical development planning and clinical trial design & execution services to the pharmaceutical and biotechnology industries. Although specialised in oncology, we also have experience in many other therapeutic areas, and have a sister company Karma Cardiology providing the same, flexible, customised services in cardiology & cardiovascular disease.
Dr Karen WilliamsPresident
Masters Speciality Pharma
Headquartered in the UK, with offices in Sao Paulo, Miami, and San Salvador. Masters Speciality Pharma has over 30 years heritage in supply and distribution of medicines in the Caribbean, Gulf States, South and Central America.
Licensed and regulated by MHRA / FDA / ANVISA / DNM / USDEA / UK Home Office, amongst others - Masters aims to provide high quality, approved, medicines to patients where they are not easily available, or yet registered, in their local markets.
Building on this legacy - Masters is now looking to acquire and register its own products in these emerging markets.
Mr Sid MastersBusiness Development Associate
Dr Will WatsonChief Business Officer
National Institute for Health Research
The NIHR Clinical Research Network provides free support and guidance to all life sciences industry companies considering running research in the UK.
We offer a free of charge, robust feasibility service to all companies that have eligible study proposals. This includes an expert protocol/synopsis review, providing national level feasibility of the "doability" and compatibility of the trial in the NHS. Along with 2 site level feasibility services, 1 of which identifies potential centers to run your trial, all done within 3 weeks
We have worked with and provided support to over 1000 different companies over the years and we are looking forward to meeting new ones at Bio-Europe Spring to whom we can support.
Mr Theo ChristieBusiness Development Manager
Ms Natalie WilsonBusiness Development Analyst
Scottish Development International
Scottish Development International offers free and confidential support to foreign companies who would like to identify commercial, clinical or academic partners in Scotland. SDI can also offer a wide range of investor support services for companies expanding in Europe.
The Scottish Life Sciences sector consists of over 650 organisations employing over 32,500 people with particular strengths in cell and gene therapy, pharmaceutical services, digital health and clinical translational medicine.
Scotland has a strong cluster of expert, innovative and ambitious companies delivering outsourcing solutions for biopharmaceutical companies globally. This includes both multi-national and niche CROs, innovative drug delivery and formulation specialists and manufacturing services that span drug development.
Dr Deborah McGregorInternational Specialist
Ms Eniko DelzenneInternational Senior Executive
Selcia Ltd is a leading provider of contract research and innovation services in Drug Discovery and 14C Radiolabelling.
Selcia Drug Discovery provides the medicinal chemistry and biology expertise and resource to accelerate your early phase drug discovery project and deliver robust preclinical candidates. Our highly experienced project managers and scientists provide innovative solutions which have resulted in co-authorship on over 30 customer patents and publications and delivery of 11 preclinical candidates, with 2 due in the clinic this year. We have also been successful in supporting biotechs in raising a total of £8 million through various bodies to fund drug discovery endeavours.
In January 2018 Selcia became part of Eurofins Pharma Discovery Services affording Selcia the capacity to deliver extensive and seamless solutions and services that span the whole spectrum of drug discovery.